Two Sigma Investments’s Phio Pharmaceuticals PHIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$57.7K Buy
56,057
+34,556
+161% +$36.5K ﹤0.01% 4744
2026
Q2
$22K Sell
21,501
-10,994
-34% -$12.5K ﹤0.01% 4981
2026
Q1
$39.6K Buy
32,495
+18,001
+124% +$20.5K ﹤0.01% 4471
2025
Q4
$15.2K Buy
+14,494
New +$23.2K ﹤0.01% 4011
2023
Q1
– Sell
-207
Closed -$8.33K – 3153
2022
Q4
$8.33K Sell
207
-8
-4% -$410 ﹤0.01% 2737
2022
Q3
$13K Sell
215
-42
-16% -$3.18K ﹤0.01% 2402
2022
Q2
$20K Buy
+257
New +$24.2K ﹤0.01% 2406
2022
Q1
– Sell
-1,192
Closed -$129K – 3926
2021
Q4
$129K Buy
1,192
+802
+206% +$128K ﹤0.01% 4013
2021
Q3
$86K Buy
390
+2
+0.5% +$418 ﹤0.01% 4100
2021
Q2
$95K Buy
+388
New +$95.6K ﹤0.01% 3904

Other funds holding PHIO

Two Sigma Investments's PHIO Position: Q3 2026 in Review

Two Sigma Investments increased its Phio Pharmaceuticals (PHIO) stake by 161% in Q3 2026, buying an estimated $36.5K and bringing the position to 56,057 shares worth $57.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4744.

Two Sigma Investments first reported a position in PHIO in Q2 2021 and has held it in 10 quarters since. The position peaked at $129K in Q4 2021. 24 funds tracked by Wall St. Rank hold PHIO as of Q3 2026.

  • Two Sigma Investments held 56,057 shares of Phio Pharmaceuticals worth $57.7K as of Q3 2026.
  • Two Sigma Investments bought 34,556 Phio Pharmaceuticals shares in Q3 2026, an estimated $36.5K.
  • Phio Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #4744 holding.
  • Two Sigma Investments first reported a position in Phio Pharmaceuticals in Q2 2021 and has held it in 10 quarters since.
  • Two Sigma Investments's Phio Pharmaceuticals position peaked at $129K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.